OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future
Laura Hesse, J. N. G. Oude Elberink, Antoon J. M. van Oosterhout, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108115-108115
Open Access | Times Cited: 25

Showing 25 citing articles:

Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27

Allergen immunotherapy for allergic asthma: The future seems bright
Zuzana Diamant, Maurits van Maaren, Antonella Muraro, et al.
Respiratory Medicine (2023) Vol. 210, pp. 107125-107125
Open Access | Times Cited: 18

Confronting allergies: strategies for combating pollution and safeguarding our health
Shakti Prasad Pattanayak, Suman Kalyan Dinda, Shreyasee Hazra, et al.
Frontiers in Allergy (2025) Vol. 5
Open Access

Advances in Allergen Immunotherapy and Safety
Samia T. Al‐Shouli
Vaccines (2025) Vol. 13, Iss. 3, pp. 221-221
Open Access

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases
Abdollah Jafarzadeh, Prashant Chauhan, Maryam Nemati, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 11, pp. 1147-1161
Closed Access | Times Cited: 9

Preventive allergen immunotherapy with inhalant allergens in children
Varsha Dwivedi, Sonja Kopanja, Klara Schmidthaler, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2065-2087
Open Access | Times Cited: 3

Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double‐blind placebo‐controlled clinical trial
Lars Ahlbeck, Emelie Ahlberg, Linn Stuivers, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 8, pp. 809-820
Open Access | Times Cited: 8

IL‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance
Patricia Vanessa Heinl, Edith Graulich, Benno Weigmann, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2826-2839
Closed Access | Times Cited: 2

Correspondence to “Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy1
I. K. P. Cheng, Chin‐Yuan Yii, Liang‐Chun Shih, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1635-1636
Closed Access | Times Cited: 1

A review of common influencing factors and possible mechanisms associated with allergic diseases complicating tic disorders in children
Panpan Zhang, Zhimin Zheng, Haowei Sun, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1

Immunotherapy against environmental fungi causing respiratory allergy
Umut Gazi, Nerin N. Bahçeciler
Journal de Mycologie Médicale (2024) Vol. 34, Iss. 4, pp. 101517-101517
Closed Access | Times Cited: 1

IgE-FcεRI protein–protein interaction as a therapeutic target against allergic asthma: An updated review
Yanjun Liu, Huiying Wang, Ran Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 284, pp. 138099-138099
Closed Access | Times Cited: 1

Immune mechanisms induced by sublingual immunotherapy in allergic respiratory diseases
Umut Gazi, Nerin N. Bahçeciler
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 3, pp. 262-269
Open Access | Times Cited: 7

Alisol B 23-Acetate Ameliorates Ovalbumin-Induced Allergic Asthma during Sensitization and Challenge Periods
Ki-Hyuk Nam, Dong‐Soon Im
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 6, pp. 611-618
Open Access | Times Cited: 3

Novel approaches for allergen-specific immunotherapy—An overview
Sakshi Sakshi, Rupa Mazumder, Monika Monika, et al.
Trends in Immunotherapy (2023) Vol. 7, Iss. 1, pp. 2026-2026
Open Access | Times Cited: 2

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice
Ž. Tempels‐Pavlica, Mark C. J. Aarts, Paco M J Welsing, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access

The spectrum of sensitization in children with respiratory allergic diseases living in the Rostov region, according to molecular allergodiagnostics
О. Е. Семерник, А. А. Лебеденко, А. М. Сарычев, et al.
Russian Journal of Allergy (2024)
Closed Access

Allergenic protein-induced type I hypersensitivity models: a review
Yanhua Feng, Lei Xu, Jinming Zhang, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access

Radioactive X-ray image examination in the treatment of allergic rhinitis asthma syndrome with traditional Chinese medicine
Cuiqing Bai, Nan Zhang, Li Han, et al.
Journal of Radiation Research and Applied Sciences (2024) Vol. 17, Iss. 4, pp. 101149-101149
Open Access

Chapter 14 : Air Quality. Fifth National Climate Assessment
J. Jason West, Christopher G. Nolte, Michelle L. Bell, et al.
(2023)
Closed Access

Page 1

Scroll to top